title: Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
abstract: Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.
authors.affiliation: National Development and Research Institutes, Center for Drug Use and HIV Research, New York, NY, 10010, USA. hagan@ndri.org
authors.forename: Holly
authors.initials: H
authors.lastname: Hagan
authors.forename: Mary H
authors.initials: MH
authors.lastname: Latka
authors.forename: Jennifer V
authors.initials: JV
authors.lastname: Campbell
authors.forename: Elizabeth T
authors.initials: ET
authors.lastname: Golub
authors.forename: Richard S
authors.initials: RS
authors.lastname: Garfein
authors.forename: David A
authors.initials: DA
authors.lastname: Thomas
authors.forename: Farzana
authors.initials: F
authors.lastname: Kapadia
authors.forename: Steffanie A
authors.initials: SA
authors.lastname: Strathdee
mesh_terms: D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D018579:Patient Selection; D012367:RNA, Viral / Q000097:blood; D012307:Risk Factors; D015819:Substance Abuse, Intravenous; D014481:United States
chemical_list: D000998:Antiviral Agents; D012367:RNA, Viral